{"title":"Pegylated liposomal adriamycin: a review of current and future applications","authors":"Conrad R Lewanski, Simon Stewart","doi":"10.1016/S1461-5347(99)00217-5","DOIUrl":null,"url":null,"abstract":"<div><p><span>Anthracyclines<span> such as adriamycin have a broad spectrum of activity in human tumours, but are limited, to an extent, by their non-selective delivery to a host of normal tissues and hence, subsequent toxicity. The development of </span></span>liposomes<span> has offered a drug delivery system with significant potential to target tumours whilst sparing normal tissues. A significant breakthrough has been achieved by coating the liposome with polyethylene glycol<span> (pegylation), and thus altering the pharmacokinetics of the drug considerably. In this review, the authors discuss the promising data now emerging with pegylated liposomal adriamycin, and also describe possible future applications.</span></span></p></div>","PeriodicalId":80125,"journal":{"name":"Pharmaceutical science & technology today","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1461-5347(99)00217-5","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical science & technology today","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1461534799002175","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11
Abstract
Anthracyclines such as adriamycin have a broad spectrum of activity in human tumours, but are limited, to an extent, by their non-selective delivery to a host of normal tissues and hence, subsequent toxicity. The development of liposomes has offered a drug delivery system with significant potential to target tumours whilst sparing normal tissues. A significant breakthrough has been achieved by coating the liposome with polyethylene glycol (pegylation), and thus altering the pharmacokinetics of the drug considerably. In this review, the authors discuss the promising data now emerging with pegylated liposomal adriamycin, and also describe possible future applications.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
